Prognostic molecular markers in early breast cancer

Keyphrases

• Early Breast Cancer 100%
• Molecular Markers 100%
• Prognostic Molecular Marker 100%
• Quantitative PCR 50%
• Breast Cancer 50%
• Prognostic Value 50%
• Human Epidermal Growth Factor Receptor 2 (HER2) 50%
• Tumor Marker 50%
• Ki-67 50%
• Cyclin D1 (CCND1) 50%
• Gene Expression Profile 50%
• Prognostic Marker 50%
• Hormone Receptor 50%
• Specific Genes 50%
• Multiple Genes 50%
• Cyclin E 50%
• Urokinase 50%
• Omics Technologies 50%
• Treatment Decisions 50%
• Cathepsin D 50%
• Proliferation Marker 50%
• Plasminogen Activator 50%
• Plasminogen Activator inhibitor-1 (PAI-1) 50%
• Archival Tissue 50%
• Gene Microarray 50%
• Molecular Potential 50%
• Breast Cancer Biology 50%

Biochemistry, Genetics and Molecular Biology

• Genetic Marker 100%
• Plasminogen Activator 66%
• Proteomics 33%
• Gene Expression 33%
• Epidermal Growth Factor Receptor 33%
• Reverse Transcription Polymerase Chain Reaction 33%
• Cyclin D1 33%
• Tumor Marker 33%
• Cyclin E 33%
• Urokinase 33%
• Hormone Receptor 33%
• Cathepsin D 33%
• Ki-67 33%